Collaborative Fund Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.12M Buy
2,142
+1,106
+107% +$566K 0.6% 45
2026
Q2
$515K Buy
1,036
+106
+11% +$47K 0.3% 96
2026
Q1
$415K Buy
+930
New +$434K 0.26% 113

Other funds holding VRTX

Collaborative Fund Advisors's VRTX Position: Q3 2026 in Review

Collaborative Fund Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 107% in Q3 2026, buying an estimated $566K and bringing the position to 2,142 shares worth $1.12M. The position accounts for 0.6% of the portfolio, ranked #45.

Collaborative Fund Advisors first reported a position in VRTX in Q1 2026 and has held it in 3 quarters since. 1,787 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Collaborative Fund Advisors held 2,142 shares of Vertex Pharmaceuticals worth $1.12M as of Q3 2026.
  • Collaborative Fund Advisors bought 1,106 Vertex Pharmaceuticals shares in Q3 2026, an estimated $566K.
  • Vertex Pharmaceuticals made up 0.6% of Collaborative Fund Advisors's portfolio in Q3 2026, its #45 holding.
  • Collaborative Fund Advisors first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 1,787 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Collaborative Fund Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.